Paroxysmal Nocturnal Hemoglobinuria Human Anti-Human Antibodies Study

Study Identifier:
M07-003
ClinicalTrials.gov Identifier:
NCT01412047
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete

Study Details

Medical Condition
  • Unmapped
Study Drug
    Date
    Mar 2012 - Jun 2013
    Phase 1
    Phase 2
    Phase 3
    Phase 4
    N/A
    Patient Requirements
    Sex: Female & Male
    Age: N/A - N/A
    Requirements Information
    Sex
    Female & Male
    Age
    N/A - N/A

    Study Details

    Medical Condition
    • Unmapped
    Study Drug
      Date
      Mar 2012 - Jun 2013
      Phase 1
      Phase 2
      Phase 3
      Phase 4
      N/A
      Patient Requirements
      Sex: Female & Male
      Age: N/A - N/A years
      Requirements Information

      Protocol Summary

      How does long term treatment with Soliris affect HAHA in PNH patients?

      Trial Locations

      Location
      Status
      Location
      University Park Hematology Oncology
      Englewood, Colorado, United States, 80113
      Status
      N/A
      Location
      Cleveland Clinic Florida
      Weston, Florida, United States, 33331
      Status
      N/A
      Location
      Maine Cancer Center of Medicine
      Scarborough, Maine, United States, 04074
      Status
      N/A
      Location
      Melbourne, Australia
      Status
      N/A
      Location
      Brussels, Belgium
      Status
      N/A
      Location
      Paris, France
      Status
      N/A